Cardiac treatment should start at home.
SafeBeat Rx is bringing cardiac care out of hospitals and into lower acuity settings, such as patients' homes. Our integrated technology enables remote patient monitoring (RPM), continuous Holter and live telemetry Monitoring, and software-enabled remote therapeutic monitoring (RTM), and implanted device monitoring - all powered by our automated and artificial intelligence-based software solutions.
In-Home Drug Monitoring.
Our proprietary combination of FDA-cleared medical devices, machine learning algorithms, remote lab testing, and optimized software provides a new care option for patients starting cardiac and other medicines.
We enable patients to stay in their home instead of traveling, missing work, and staying in a hospital.
Remote Patient Monitoring, Holter and Mobile Cardiac Telemetry & Health Tracking Services.
Our unique devices and algorithms are designed to help clinicians quickly see the full picture without being buried in notifications. All software is designed for physicians, by physicians.
With patient and clinician experience at the top of our mind, we're delivering exceptional compliance and impact in remote care.
Advanced Artificial Intelligence API.
Our proprietary algorithms power all of our solutions, and we are making them available to power your products as well.
From ECG interpretation to treatment management, our world-class AI delivers higher efficiency and superior insights.
Meet the team.
Rachita Navara, MD.
Founder and CEO
Dr. Navara is a bioengineer and cardiologist specializing in heart rhythm disorders. She has been internationally recognized for her atrial fibrillation research, and she has led numerous award-winning medical innovation teams within academia (Stanford, UCSF, Wash U, MIT, Olin College of Engineering, UT Southwestern) and industry (Boston Scientific, Preserve, Harvard Brigham and Women’s Hospital). She is an appointed member of the National ACC Heart Rhythm Leadership Council and is HRS delegate to the AMA, directly shaping arrhythmia treatment guidelines.
Kunj Patel, MD, MSc.
President, Founder, and CTO
Dr. Patel is a physical medicine and interventional pain physician from Harvard, Emory, Wash U, and NJIT with masters-level expertise in applied mathematics/numerical methods and translational research. He was a White House Presidential Leadership Scholar finalist and executive board member of multiple professional medical societies. Prior to SafeBeat Rx, he built a private practice clinic centered on a fully integrated remote monitoring platform he developed to facilitate care during the COVID-19 pandemic.
John Higgins, BSc.
Director of Engineering
Mr. Higgins brings 13 years’ experience in software engineering and artificial intelligence platforms, including managing the entire end-to-end software development lifecycle. As Founding Engineering Director for a Non-Profit R&D lab in Silicon Valley and Product Innovation Manager at Athenahealth, he brought countless products to end-users including executing a 150,000+ user, cloud SaaS environment interfacing with 29,000 healthcare providers.
Alejandro Alvarez, MSc.
Founding and Lead Engineer
Mr. Alvarez is a Senior Full-stack and Machine learning Software Engineer who has over ten years of experience, including at Fortune 500 companies, like Morgan Stanley, where he worked as a Senior Software engineer. He has a background in signal processing and telecommunication, and previously helped scale Wise.com through to a successful IPO as part of their debit card and machine learning engineering teams.
Ben Sackett, MSc.
Head of Operations & Technical Lead
Mr. Sackett, is SafeBeat’s Head of Operations and Technical Operations Lead, and he is a former senior engineer at Genentech, where he worked for 8 years and previously managed top software development teams. He also brings a wealth of knowledge from the pharmaceutical industry regarding clinical trials and commercialization, having helped with the rollout of novel products to millions of people around the globe. He leads SafeBeat’s early partnerships and growth strategies.
Rania deLeon, BSc.
Regulatory Affairs Manager
Rania deLeon is a biomedical engineer who brings seven years of experience in the medical device industry in both quality assurance and regulatory affairs, specifically in the area of cardiac electrophysiology. In her career, she has gotten medical device approvals from the FDA, Health Canada, European Union, and Australia, and has built electronic quality management systems from the ground up. Her approved devices are being used by thousands of cardiologists across the world today.
SafeBeat Rx CEO, Dr. Rachita Navara, recognized for AI Leadership & Entrepreneurship Awards by VentureBeat
Since 2019, VentureBeat has been honoring the women leaders, mentors, researchers and entrepreneurs who are transforming the AI industry — making it magnitudes more equitable, ethical and groundbreaking for all.
MedTech Innovator Announces Top 50 Startups in 2022
MedTech Innovator, the world’s largest accelerator of medical technology companies, today announced the 50 companies selected to participate in the organization’s flagship four-month Accelerator program, featuring medical device, diagnostic, and digital health technologies from around the globe.
The Pulse Celebrates SafeBeat Rx CEO, Dr. Rachita Navara
Rachita Navara, CEO and cofounder of Safebeat RX, received a first funding of $120K. SafeBeat Rx replaces a hospitalization with a take-home kit that combines FDA-approved wearables with life-saving ECG software that expands access to proven heart therapies.
Olin College of Engineering recognizes SafeBeat Rx CEO, Dr. Rachita Navara
As valedictorian and Outstanding Senior Student at the acclaimed Signature School in Indiana, Dr. Rachita Navara ’11 had her pick of top engineering schools from MIT to Caltech—but for her, Olin stood out from all the rest.
SafeBeat Rx featured as top YCombinator S21 startup by TechCrunch
YCombinator kicked off its fourth-ever virtual Demo Day today, revealing the first half of its nearly 400-company batch. The presentation, YC’s biggest yet, offers a snapshot into where innovation is heading, from not-so-simple seaweed to a Clearco for creators.
Zillionize Invests in SafeBeat Rx
SafeBeat Rx are making life-saving electrocardiogram (ECG) software to replace a three-day hospitalization that’s required to monitor patients starting new heart medication. With their software that provides accurate remote heart readings, patients are able to start this new medication safely at home.
SafeBeat Rx CEO highlighted by MIT's venture firm, Engine
Blueprint is a nonresident program for graduate students, postdocs, research scientists, faculty members, and their teams, to explore the commercial opportunities of their breakthroughs and startup projects.
SafeBeat Rx named winner in SVC Competition
On April 26, 2021, finalists will compete for $22,500 in awards in the Spring 2021 Skandalaris Venture Competition. In anticipation of the SVC finals, we are publishing a Q&A series with the finalists. Today’s featured team is SafeBeat Rx. SafeBeat Rx is developing machine learning technology that aims to expand access to important (at times, life-saving) heart medications.